ID   LYOX_HUMAN              Reviewed;         417 AA.
AC   P28300; B2R5Q3; Q5FWF0;
DT   01-DEC-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1993, sequence version 2.
DT   10-MAY-2017, entry version 170.
DE   RecName: Full=Protein-lysine 6-oxidase;
DE            EC=1.4.3.13 {ECO:0000269|PubMed:26838787};
DE   AltName: Full=Lysyl oxidase;
DE   Flags: Precursor;
GN   Name=LOX;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1685472; DOI=10.1016/0888-7543(91)90057-L;
RA   Haemaelaeinen E.-R., Jones T.A., Sheer D., Taskinen K.,
RA   Pihlajaniemi T., Kivirikko K.I.;
RT   "Molecular cloning of human lysyl oxidase and assignment of the gene
RT   to chromosome 5q23.3-31.2.";
RL   Genomics 11:508-516(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Skin;
RX   PubMed=1357535;
RA   Mariani T.J., Trackman P.C., Kagan H.M., Eddy R.L., Shows T.B.,
RA   Boyd C.D., Deak S.B.;
RT   "The complete derived amino acid sequence of human lysyl oxidase and
RT   assignment of the gene to chromosome 5 (extensive sequence homology
RT   with the murine ras recision gene).";
RL   Matrix 12:242-248(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RX   PubMed=7706256; DOI=10.1074/jbc.270.13.7176;
RA   Kim Y., Boyd C.D., Csiszar K.;
RT   "A new gene with sequence and structural similarity to the gene
RT   encoding human lysyl oxidase.";
RL   J. Biol. Chem. 270:7176-7182(1995).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10391127; DOI=10.1023/A:1006913122261;
RA   Contente S., Kenyon K., Sriraman P., Subramanyan S., Friedman R.M.;
RT   "Epigenetic inhibition of lysyl oxidase transcription after
RT   transformation by ras oncogene.";
RL   Mol. Cell. Biochem. 194:79-91(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLN-158.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-213.
RX   PubMed=7902322; DOI=10.1006/geno.1993.1369;
RA   Haemaelaeinen E.-R., Kemppainen R., Pihlajaniemi T., Kivirikko K.I.;
RT   "Structure of the human lysyl oxidase gene.";
RL   Genomics 17:544-548(1993).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 55-216.
RC   TISSUE=Blood;
RX   PubMed=1352776;
RA   Svinarich D.M., Twomey T.A., Macauley S.P., Krebs C.J., Yang T.P.,
RA   Krawetz S.A.;
RT   "Characterization of the human lysyl oxidase gene locus.";
RL   J. Biol. Chem. 267:14382-14387(1992).
RN   [9]
RP   INTERACTION WITH MFAP4.
RX   PubMed=26601954; DOI=10.1074/jbc.M115.681775;
RA   Pilecki B., Holm A.T., Schlosser A., Moeller J.B., Wohl A.P.,
RA   Zuk A.V., Heumueller S.E., Wallis R., Moestrup S.K., Sengle G.,
RA   Holmskov U., Sorensen G.L.;
RT   "Characterization of microfibrillar-associated protein 4 (MFAP4) as a
RT   tropoelastin- and fibrillin-binding protein involved in elastic fiber
RT   formation.";
RL   J. Biol. Chem. 291:1103-1114(2016).
RN   [10]
RP   VARIANT GLN-158.
RX   PubMed=8100215; DOI=10.1006/geno.1993.1203;
RA   Csiszar K., Mariani T.J., Gosin J.S., Deak S.B., Boyd C.D.;
RT   "A restriction fragment length polymorphism results in a
RT   nonconservative amino acid substitution encoded within the first exon
RT   of the human lysyl oxidase gene.";
RL   Genomics 16:401-406(1993).
RN   [11]
RP   VARIANTS AAT10 THR-79; PHE-154; ILE-248; PRO-267; ILE-280 AND ARG-348,
RP   CHARACTERIZATION OF VARIANTS AAT10 THR-79; PHE-154; ILE-248; PRO-267;
RP   ARG-280 AND ARG-348, INVOLVEMENT IN AAT10, FUNCTION, AND CATALYTIC
RP   ACTIVITY.
RX   PubMed=26838787; DOI=10.1161/CIRCRESAHA.115.307130;
RG   University of Washington Center for Mendelian Genomics;
RA   Guo D.C., Regalado E.S., Gong L., Duan X., Santos-Cortez R.L.,
RA   Arnaud P., Ren Z., Cai B., Hostetler E.M., Moran R., Liang D.,
RA   Estrera A., Safi H.J., Leal S.M., Bamshad M.J., Shendure J.,
RA   Nickerson D.A., Jondeau G., Boileau C., Milewicz D.M.;
RT   "LOX mutations predispose to thoracic aortic aneurysms and
RT   dissections.";
RL   Circ. Res. 118:928-934(2016).
RN   [12]
RP   VARIANT AAT10 ARG-298, AND CHARACTERIZATION OF VARIANT AAT10 ARG-298.
RX   PubMed=27432961; DOI=10.1073/pnas.1601442113;
RG   Brigham Genomic Medicine;
RA   Lee V.S., Halabi C.M., Hoffman E.P., Carmichael N., Leshchiner I.,
RA   Lian C.G., Bierhals A.J., Vuzman D., Mecham R.P., Frank N.Y.,
RA   Stitziel N.O.;
RT   "Loss of function mutation in LOX causes thoracic aortic aneurysm and
RT   dissection in humans.";
RL   Proc. Natl. Acad. Sci. U.S.A. 113:8759-8764(2016).
CC   -!- FUNCTION: Responsible for the post-translational oxidative
CC       deamination of peptidyl lysine residues in precursors to fibrous
CC       collagen and elastin (PubMed:26838787). Regulator of Ras
CC       expression. May play a role in tumor suppression. Plays a role in
CC       the aortic wall architecture (By similarity).
CC       {ECO:0000250|UniProtKB:P28301, ECO:0000269|PubMed:26838787}.
CC   -!- CATALYTIC ACTIVITY: [Protein]-L-lysine + O(2) + H(2)O = [protein]-
CC       (S)-2-amino-6-oxohexanoate + NH(3) + H(2)O(2).
CC       {ECO:0000269|PubMed:26838787}.
CC   -!- COFACTOR:
CC       Name=Cu cation; Xref=ChEBI:CHEBI:23378;
CC         Evidence={ECO:0000250|UniProtKB:P16636};
CC   -!- COFACTOR:
CC       Name=lysine tyrosylquinone residue; Xref=ChEBI:CHEBI:20489;
CC         Evidence={ECO:0000250|UniProtKB:P33072};
CC       Note=Contains 1 lysine tyrosylquinone.
CC       {ECO:0000250|UniProtKB:P33072};
CC   -!- SUBUNIT: Interacts with MFAP4 (PubMed:26601954).
CC       {ECO:0000269|PubMed:26601954}.
CC   -!- INTERACTION:
CC       O95967:EFEMP2; NbExp=4; IntAct=EBI-3893481, EBI-743414;
CC       P15502:ELN; NbExp=2; IntAct=EBI-3893481, EBI-1222108;
CC       Q9UBX5:FBLN5; NbExp=2; IntAct=EBI-3893481, EBI-947897;
CC       P35555:FBN1; NbExp=2; IntAct=EBI-3893481, EBI-2505934;
CC       Q15262:PTPRK; NbExp=4; IntAct=EBI-3893481, EBI-474052;
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250|UniProtKB:P28301}.
CC       Secreted, extracellular space.
CC   -!- TISSUE SPECIFICITY: Heart, placenta, skeletal muscle, kidney, lung
CC       and pancreas. {ECO:0000269|PubMed:7706256}.
CC   -!- PTM: The lysine tyrosylquinone cross-link (LTQ) is generated by
CC       condensation of the epsilon-amino group of a lysine with a
CC       topaquinone produced by oxidation of tyrosine.
CC       {ECO:0000250|UniProtKB:P33072}.
CC   -!- PTM: Proteolytically activated by BMP1. {ECO:0000250}.
CC   -!- DISEASE: Aortic aneurysm, familial thoracic 10 (AAT10)
CC       [MIM:617168]: A form of thoracic aortic aneurysm, a disease
CC       characterized by permanent dilation of the thoracic aorta usually
CC       due to degenerative changes in the aortic wall. It is primarily
CC       associated with a characteristic histologic appearance known as
CC       'medial necrosis' or 'Erdheim cystic medial necrosis' in which
CC       there is degeneration and fragmentation of elastic fibers, loss of
CC       smooth muscle cells, and an accumulation of basophilic ground
CC       substance. {ECO:0000269|PubMed:26838787,
CC       ECO:0000269|PubMed:27432961}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: The propeptide plays a role in directing the
CC       deposition of this enzyme to elastic fibers, via interaction with
CC       tropoelastin. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the lysyl oxidase family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/LOXID41191ch5q23.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; S78694; AAB21243.1; -; mRNA.
DR   EMBL; M94054; AAA59525.1; -; mRNA.
DR   EMBL; S45875; AAB23549.1; -; mRNA.
DR   EMBL; AF039291; AAD02130.1; -; mRNA.
DR   EMBL; AK312269; BAG35200.1; -; mRNA.
DR   EMBL; BC074820; AAH74820.1; -; mRNA.
DR   EMBL; BC074872; AAH74872.1; -; mRNA.
DR   EMBL; BC089436; AAH89436.1; -; mRNA.
DR   EMBL; L16895; AAA16870.1; -; Genomic_DNA.
DR   EMBL; M84150; AAA59541.1; -; Genomic_DNA.
DR   CCDS; CCDS4129.1; -.
DR   PIR; A47529; OXHUL.
DR   RefSeq; NP_002308.2; NM_002317.6.
DR   UniGene; Hs.102267; -.
DR   ProteinModelPortal; P28300; -.
DR   BioGrid; 110199; 10.
DR   DIP; DIP-49007N; -.
DR   IntAct; P28300; 41.
DR   STRING; 9606.ENSP00000231004; -.
DR   BindingDB; P28300; -.
DR   ChEMBL; CHEMBL2249; -.
DR   iPTMnet; P28300; -.
DR   PhosphoSitePlus; P28300; -.
DR   UniCarbKB; P28300; -.
DR   BioMuta; LOX; -.
DR   EPD; P28300; -.
DR   MaxQB; P28300; -.
DR   PaxDb; P28300; -.
DR   PeptideAtlas; P28300; -.
DR   PRIDE; P28300; -.
DR   Ensembl; ENST00000231004; ENSP00000231004; ENSG00000113083.
DR   GeneID; 4015; -.
DR   KEGG; hsa:4015; -.
DR   UCSC; uc003ksu.4; human.
DR   CTD; 4015; -.
DR   DisGeNET; 4015; -.
DR   GeneCards; LOX; -.
DR   HGNC; HGNC:6664; LOX.
DR   HPA; HPA043930; -.
DR   MIM; 153455; gene.
DR   MIM; 617168; phenotype.
DR   neXtProt; NX_P28300; -.
DR   OpenTargets; ENSG00000113083; -.
DR   PharmGKB; PA30427; -.
DR   eggNOG; ENOG410IHTH; Eukaryota.
DR   eggNOG; ENOG41101E4; LUCA.
DR   GeneTree; ENSGT00870000136394; -.
DR   HOGENOM; HOG000234262; -.
DR   HOVERGEN; HBG000226; -.
DR   InParanoid; P28300; -.
DR   KO; K00277; -.
DR   OMA; YSDDNPY; -.
DR   OrthoDB; EOG091G02XD; -.
DR   PhylomeDB; P28300; -.
DR   TreeFam; TF326061; -.
DR   BRENDA; 1.4.3.13; 2681.
DR   Reactome; R-HSA-1566948; Elastic fibre formation.
DR   Reactome; R-HSA-2243919; Crosslinking of collagen fibrils.
DR   ChiTaRS; LOX; human.
DR   GeneWiki; Lysyl_oxidase; -.
DR   GenomeRNAi; 4015; -.
DR   PMAP-CutDB; P28300; -.
DR   PRO; PR:P28300; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000113083; -.
DR   CleanEx; HS_LOX; -.
DR   ExpressionAtlas; P28300; baseline and differential.
DR   Genevisible; P28300; HS.
DR   GO; GO:0005581; C:collagen trimer; IEA:Ensembl.
DR   GO; GO:0005576; C:extracellular region; ISS:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IEA:Ensembl.
DR   GO; GO:0005578; C:proteinaceous extracellular matrix; IEA:Ensembl.
DR   GO; GO:0005507; F:copper ion binding; TAS:ProtInc.
DR   GO; GO:0004720; F:protein-lysine 6-oxidase activity; ISS:UniProtKB.
DR   GO; GO:0035904; P:aorta development; IEA:Ensembl.
DR   GO; GO:0048514; P:blood vessel morphogenesis; ISS:UniProtKB.
DR   GO; GO:0006464; P:cellular protein modification process; TAS:ProtInc.
DR   GO; GO:0030199; P:collagen fibril organization; IEA:Ensembl.
DR   GO; GO:0048251; P:elastic fiber assembly; IEA:Ensembl.
DR   GO; GO:0030198; P:extracellular matrix organization; TAS:Reactome.
DR   GO; GO:0007507; P:heart development; IEA:Ensembl.
DR   GO; GO:0030324; P:lung development; IEA:Ensembl.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0048545; P:response to steroid hormone; IEA:Ensembl.
DR   GO; GO:0042060; P:wound healing; IEA:Ensembl.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR001695; Lysyl_oxidase.
DR   InterPro; IPR019828; Lysyl_oxidase_CS.
DR   Pfam; PF01186; Lysyl_oxidase; 1.
DR   PRINTS; PR00074; LYSYLOXIDASE.
DR   PROSITE; PS00926; LYSYL_OXIDASE; 1.
PE   1: Evidence at protein level;
KW   Aortic aneurysm; Complete proteome; Copper; Disease mutation;
KW   Disulfide bond; Glycoprotein; LTQ; Metal-binding; Oxidoreductase;
KW   Polymorphism; Reference proteome; Secreted; Signal; TPQ.
FT   SIGNAL        1     21       {ECO:0000250|UniProtKB:P16636}.
FT   PROPEP       22    168       {ECO:0000250|UniProtKB:P16636}.
FT                                /FTId=PRO_0000018520.
FT   CHAIN       169    417       Protein-lysine 6-oxidase.
FT                                /FTId=PRO_0000018521.
FT   REGION      213    417       Lysyl-oxidase like.
FT   METAL       292    292       Copper. {ECO:0000255}.
FT   METAL       294    294       Copper. {ECO:0000255}.
FT   METAL       296    296       Copper. {ECO:0000255}.
FT   MOD_RES     355    355       2',4',5'-topaquinone.
FT                                {ECO:0000250|UniProtKB:P33072}.
FT   CARBOHYD     81     81       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     97     97       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    144    144       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    238    244       {ECO:0000250|UniProtKB:P33072}.
FT   DISULFID    291    340       {ECO:0000250|UniProtKB:P33072}.
FT   DISULFID    324    330       {ECO:0000250|UniProtKB:P33072}.
FT   DISULFID    351    361       {ECO:0000250|UniProtKB:P33072}.
FT   DISULFID    398    412       {ECO:0000250|UniProtKB:P33072}.
FT   CROSSLNK    320    355       Lysine tyrosylquinone (Lys-Tyr).
FT                                {ECO:0000250|UniProtKB:P33072}.
FT   VARIANT      79     79       A -> T (in AAT10; unknown pathological
FT                                significance; dbSNP:rs752839330).
FT                                {ECO:0000269|PubMed:26838787}.
FT                                /FTId=VAR_077534.
FT   VARIANT     154    154       L -> F (in AAT10; unknown pathological
FT                                significance; dbSNP:rs767855588).
FT                                {ECO:0000269|PubMed:26838787}.
FT                                /FTId=VAR_077535.
FT   VARIANT     158    158       R -> Q (in dbSNP:rs1800449).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:8100215}.
FT                                /FTId=VAR_004282.
FT   VARIANT     248    248       T -> I (in AAT10; unknown pathological
FT                                significance; 8% decrease of lysyl
FT                                oxidase activity).
FT                                {ECO:0000269|PubMed:26838787}.
FT                                /FTId=VAR_077536.
FT   VARIANT     267    267       Q -> P (in AAT10).
FT                                {ECO:0000269|PubMed:26838787}.
FT                                /FTId=VAR_077537.
FT   VARIANT     280    280       S -> I (in AAT10; 50% decrease of lysyl
FT                                oxidase activity).
FT                                {ECO:0000269|PubMed:26838787}.
FT                                /FTId=VAR_077538.
FT   VARIANT     298    298       M -> R (in AAT10).
FT                                {ECO:0000269|PubMed:27432961}.
FT                                /FTId=VAR_077539.
FT   VARIANT     348    348       S -> R (in AAT10; 21% decrease of lysyl
FT                                oxidase activity).
FT                                {ECO:0000269|PubMed:26838787}.
FT                                /FTId=VAR_077540.
FT   CONFLICT     30     30       Q -> H (in Ref. 3). {ECO:0000305}.
FT   CONFLICT     31     31       P -> A (in Ref. 3). {ECO:0000305}.
FT   CONFLICT     95     95       R -> A (in Ref. 3). {ECO:0000305}.
FT   CONFLICT    102    102       A -> G (in Ref. 1; AAB21243).
FT                                {ECO:0000305}.
FT   CONFLICT    137    137       A -> R (in Ref. 2; AAA59525/AAB23549).
FT                                {ECO:0000305}.
FT   CONFLICT    139    139       A -> P (in Ref. 1; AAB21243).
FT                                {ECO:0000305}.
FT   CONFLICT    304    305       YD -> LY (in Ref. 1; AAB21243).
FT                                {ECO:0000305}.
FT   CONFLICT    315    315       V -> W (in Ref. 1; AAB21243).
FT                                {ECO:0000305}.
SQ   SEQUENCE   417 AA;  46944 MW;  6412A78443E03F04 CRC64;
     MRFAWTVLLL GPLQLCALVH CAPPAAGQQQ PPREPPAAPG AWRQQIQWEN NGQVFSLLSL
     GSQYQPQRRR DPGAAVPGAA NASAQQPRTP ILLIRDNRTA AARTRTAGSS GVTAGRPRPT
     ARHWFQAGYS TSRAREAGAS RAENQTAPGE VPALSNLRPP SRVDGMVGDD PYNPYKYSDD
     NPYYNYYDTY ERPRPGGRYR PGYGTGYFQY GLPDLVADPY YIQASTYVQK MSMYNLRCAA
     EENCLASTAY RADVRDYDHR VLLRFPQRVK NQGTSDFLPS RPRYSWEWHS CHQHYHSMDE
     FSHYDLLDAN TQRRVAEGHK ASFCLEDTSC DYGYHRRFAC TAHTQGLSPG CYDTYGADID
     CQWIDITDVK PGNYILKVSV NPSYLVPESD YTNNVVRCDI RYTGHHAYAS GCTISPY
//
